<div class='circular--portrait' style='background:#FF0F00;color: #FFFFF0;font-size:4em;padding-top: 25px;;'>AP</div>
Understanding current and past ASTREZENECA PHARMA Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. We suggest to use ASTREZENECA PHARMA fundamental analysis to find out if markets are now mispricing the company. Put another way you can use it to find out if ASTREZENECA PHARMA is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to analyze and collect data for twenty-nine available fundamental indicators for ASTREZENECA PHARMA, which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all ASTREZENECA PHARMA financials, including its ebitda, number of employees, last dividend paid, as well as the relationship between the current ratio and working capital .

Search Fundamentals

With this module, you can analyze ASTREZENECA financials for your investing period. You should be able to track the changes in ASTREZENECA PHARMA individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.

Chance of Financial Distress

ASTREZENECA PHARMA has less than 45 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for ASTREZENECA PHARMA stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info


ASTREZENECA PHARMA competes with IFCI. AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, distributes, and markets pharmaceutical products in India and internationally. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca PLC. AstraZeneca Pharma operates under Drug Manufacturers - Major classification in India and is traded on National Stock Exchange of India. It employs 1452 people.
InstrumentIndia Stock View All
ExchangeNational Stock Exchange of India
Business AddressManyata Embassy Business
IndustryDrug Manufacturers - Major
Phone91 80 6774 8000


ASTREZENECA Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ASTREZENECA PHARMA's current stock value. Our valuation model uses many indicators to compare ASTREZENECA PHARMA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ASTREZENECA PHARMA competition to find correlations between indicators driving ASTREZENECA PHARMA's intrinsic value. More Info.
ASTREZENECA PHARMA is the top company in revenue category among related companies. It is number one stock in operating margin category among related companies . The ratio of Revenue to Operating Margin for ASTREZENECA PHARMA is about  936,936,937 

ASTREZENECA PHARMA Market Fundamentals

Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Check out Trending Equities. Please also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page